World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
63
Citations
17141
World Ranking
10079
National Ranking
730

Overview

Gudrun Göhring is affiliated with Hannover Medical School in Germany and has an extensive publication record primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work spans multiple subfields, including Molecular Biology, Hematology, Genetics, Pulmonary and Respiratory Medicine, and Public Health, Environmental and Occupational Health.

Their research topics cover a variety of areas related to hematological malignancies and genetic research, focusing on:

  • Acute Myeloid Leukemia Research
  • Pluripotent Stem Cells Research
  • Acute Lymphoblastic Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • CRISPR and Genetic Engineering
  • Cancer Genomics and Diagnostics
  • Chronic Lymphocytic Leukemia Research

Frequent coauthors in their publications include Brigitte Schlegelberger, Yvonne Lisa Behrens, Charlotte M. Niemeyer, Miriam Erlacher, and Brigitte Strahm.

Key publication venues where they have contributed multiple times include Stem Cell Research, Blood, EJC Paediatric Oncology, Leukemia, and Haematologica.

Among notable recent papers authored are:

  • Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes, 2021, Nature Medicine
  • Chromothripsis followed by circular recombination drives oncogene amplification in human cancer, 2021, Nature Genetics
  • Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial, 2020, Blood
  • The Clinical Utility of Optical Genome Mapping for the Assessment of Genomic Aberrations in Acute Lymphoblastic Leukemia, 2021, Cancers
  • IDH1/2 mutations in acute myeloid leukemia patients and risk of coronary artery disease and cardiac dysfunction-a retrospective propensity score analysis, 2020, Leukemia

Best Publications

  • Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

    Stefan Stein;Marion G. Ott;Stephan Schultze-Strasser;Anna Jauch

  • Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

    Christian Jörg Braun;Kaan Boztug;Anna Paruzynski;Maximilian Witzel

  • TP53 Mutations in Low-Risk Myelodysplastic Syndromes With del(5q) Predict Disease Progression

    Martin Jädersten;Leonie Saft;Alexander Smith;Austin Kulasekararaj

  • Frequency and prognostic impact of mutations in SRSF2, U2AF1, and ZRSR2 in patients with myelodysplastic syndromes

    Felicitas Thol;Sofia Kade;Carola Schlarmann;Patrick Löffeld

  • Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML).

    B. Hanfstein;M. C. Müller;R. Hehlmann;P. Erben

  • Incidence and Prognostic Influence of DNMT3A Mutations in Acute Myeloid Leukemia

    Felicitas Thol;Frederik Damm;Andrea Lüdeking;Claudia Winschel

  • The impact of therapy-related acute myeloid leukemia (AML) on outcome in 2853 adult patients with newly diagnosed AML.

    Sabine Kayser;Konstanze Döhner;Jürgen Krauter;Claus Henning Köhne

  • Monitoring of Minimal Residual Disease in NPM1-Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

    Jan Krönke;Richard F. Schlenk;Kai-Ole Jensen;Florian Tschürtz

  • Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents.

    Marcin W. Wlodarski;Marcin W. Wlodarski;Shinsuke Hirabayashi;Victor Pastor;Jan Starý

  • Myelodysplastic Syndromes Are Propagated by Rare and Distinct Human Cancer Stem Cells In Vivo

    Petter S. Woll;Una Kjällquist;Onima Chowdhury;Helen Doolittle

  • Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV

    Alice Fabarius;Armin Leitner;Andreas Hochhaus;Martin C. Müller

  • Prognostic Significance of ASXL1 Mutations in Patients With Myelodysplastic Syndromes

    Felicitas Thol;Inna Friesen;Frederik Damm;Haiyang Yun

  • Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor

    Katharina Wagner;Frederik Damm;Gudrun Göhring;Kerstin Görlich

  • Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia

    Jan Krönke;Lars Bullinger;Veronica Teleanu;Florian Tschürtz

  • Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.

    Felicitas Thol;Razif Gabdoulline;Alessandro Liebich;Piroska Klement

  • Persistent malignant stem cells in del(5q) myelodysplasia in remission.

    Ramin Tehranchi;Petter S Woll;Kristina Anderson;Natalija Buza-Vidas

  • IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis

    Felicitas Thol;Eva M. Weissinger;Jürgen Krauter;Katharina Wagner

  • Prognostic impact of IDH2 mutations in cytogenetically normal acute myeloid leukemia

    Felicitas Thol;Frederik Damm;Katharina Wagner;Gudrun Göhring

  • Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications

    Felicitas Thol;Robin Bollin;Marten Gehlhaar;Carolin Walter

  • Monosomal karyotype in adult acute myeloid leukemia: prognostic impact and outcome after different treatment strategies

    Sabine Kayser;Manuela Zucknick;Konstanze Döhner;Jürgen Krauter

Frequent Co-Authors

Brigitte Schlegelberger
Brigitte Schlegelberger Hannover Medical School
Arnold Ganser
Arnold Ganser Hannover Medical School
Michael Heuser
Michael Heuser Hannover Medical School
Charlotte M. Niemeyer
Charlotte M. Niemeyer University of Freiburg
Doris Steinemann
Doris Steinemann Hannover Medical School
Konstanze Döhner
Konstanze Döhner University of Ulm
Hartmut Döhner
Hartmut Döhner University of Ulm
Richard F. Schlenk
Richard F. Schlenk University Hospital Heidelberg
Hans Kreipe
Hans Kreipe Hannover Medical School
Michael Lübbert
Michael Lübbert University of Freiburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Biology and Biochemistry in the USA opens a wide array of online degree options and exciting career pathways. For those interested in healthcare, an online asn program offers a foundation in nursing with the flexibility of remote study. This pathway is ideal for students aiming to enter the workforce quickly as licensed practical or registered nurses.

If you’re passionate about how nutrition impacts health, consider an online degree in nutrition. This qualification prepares you for roles in dietetics, public health, and wellness coaching, blending science with real-world application.

Advancing into leadership positions in the healthcare sector is possible with a master’s degree. The top online mha programs that are cahme accredited equip students with management and policy skills sought by hospitals and healthcare organizations.

For those aspiring to the highest level of clinical nursing practice, explore online dnp programs that offer advanced study—some without mandatory clinical components for added convenience.

Exploring these online degrees can help you tailor your academic journey and career ambitions within the dynamic world of biological and health sciences.

Best Scientists Citing Gudrun Göhring

Trending Scientists

Recently Published Articles